Many leading biologic medicines are slated to lose patent protection in the coming years, which will create considerable opportunity for both manufacturers and consumers. Like generic drugs, biosimilars can help lower drug costs. However, biosimilars differ from generics in a few key ways; at the most basic level, generics are identical to their reference drugs, whereas biosimilars are only similar to theirs.
Download this free infographic and learn:
- Key differences between these two drug types
- Potential benefits of using one over the other
- Pros and cons of each drug type
Like this article? Click here to subscribe to free newsletters from Lab Manager